Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 2

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 2
---
PECTUS REVELATION BIOSCIENCES, INC. Up to [•] Shares of Common Stock [•] Pre-Funded Warrants to Purchase up to [•] Shares of Common Stock and up to [•] Shares of Common Stock Underlying the Pre-Funded Warrants Up to [•] Common Stock Warrants to Purchase up to [•] Shares of Common Stock and up to [•] Shares of Common Stock Underlying the Common Stock Warrants This is a best efforts public offering of [•] shares of our common stock, warrants to purchase up to [•] shares of our common stock (which we refer to as “Common Stock Warrants”), and the shares of common stock underlying the Common Stock Warrants, at a combined public offering price of $• per share of common stock and accompanying Common Stock Warrants. Each Common Stock Warrant is exercisable immediately for one share of common stock at an exercise price of $share and will expire five years from the initial exercise date. We are also offering to those purchasers, if any, whose purchase of common stock in this offering would otherwise result in any such purchaser, together with its affiliates, beneficially owning more than 4.99% (or, at the election of such purchaser, 9.99%) of our outstanding common stock immediately following the consummation of this offering, the opportunity to purchase pre -fundedwarrants in lieu of shares of our common stock that would otherwise result in such purchaser’s beneficial ownership exceeding 4.99% (or, at the election of such purchaser, 9.99%) of our outstanding common stock. The purchase price for each pre -fundedwarrant will equal the per share public offering price for the common stock in this offering less the $0.0001 per share exercise price of each such pre -fundedwarrant. Each pre -fundedwarrant will be exercisable upon issuance and will not expire prior to exercise. This prospectus also relates to the shares of common stock that are issuable from time to time upon exercise of the pre -fundedwarrants and Common Stock Warrants. Our common stock is quoted for trading on the Nasdaq Capital Market under the symbol “REVB”. On April [•], 2025, the last reported sales price for our common stock was $[•] per share, which reflects the reverse stock split described below. The actual public offering price per share and accompanying Common Stock Warrants will be determined between us, the Placement Agent and the